Why VEGF + PD-1 are logical choices for combination therapy in mRCC?

Why VEGF + PD-1 are logical choices for combination therapy in mRCC?

User Photo
kidneycancer

3 years
630 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David McDermott, MD of Dana Farber answers the question Why VEGF + PD-1 are logical choices for combination therapy in mRCC?
Up Next Autoplay
>